CoChat

Zopiclone Increases the Arousal Threshold without Impairing Genioglossus Activity in Obstructive Sleep Apnea

Open access
Carter, Sophie G., Berger, Michael S., Carberry, Jayne C., Bilston, Lynne E., Butler, Jane E., Tong, Benjamin K.Y., Martins, Rodrigo T., Fisher, Lauren P., McKenzie, David K., Grunstein, Ronald R., Eckert, Danny J. · 2016 · Sleep
Cited by 105

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

To determine the effects of the nonbenzodiazepine sedative zopiclone on the threshold to arousal with increasing respiratory effort and genioglossus muscle activity and to examine potential physiological factors mediating disparate effects of zopiclone on obstructive sleep apnea (OSA) severity between patients. Twelve patients with OSA (apnea-hypopnea index = 41 ± 8 events/h) were studied during 2 single night sleep studies conducted approximately 1 w apart after receiving 7.5 mg of zopiclone or placebo according to a double-blind, placebo-controlled, randomized, crossover design. The respiratory arousal threshold (epiglottic pressure immediately prior to arousal during naturally occurring respiratory events), genioglossus activity and its responsiveness to pharyngeal pressure during respiratory events, and markers of OSA severity were compared between conditions. Genioglossus movement patterns and upper airway anatomy were also assessed via magnetic resonance imaging in a subset of participants (n = 7) during wakefulness. Zopiclone increased the respiratory arousal threshold versus placebo (−31.8 ± 5.6 versus −26.4 ± 4.6 cmH2O, P = 0.02) without impairing genioglossus muscle activity or its responsiveness to negative pharyngeal pressure during respiratory events (−0.56 ± 0.2 versus −0.44 ± 0.1 %max/-cmH2O, P = 0.48). There was substantial interindividual variability in the changes in OSA severity with zopiclone explained, at least in part, by differences in pathophysiological characteristics including body mass index, arousal threshold, and genioglossus movement patterns. In a group of patients with predominantly severe OSA, zopiclone increased the arousal threshold without reducing genioglossus muscle activity or its responsiveness to negative pharyngeal pressure. These properties may be beneficial in some patients with OSA with certain pathophysiological characteristics but may worsen hypoxemia in others. Australian New Zealand Clinical Trials Registry, http://www.anzctr.org.au, trial ID: ACTRN12614000364673. Sedative use in obstructive sleep apnea (OSA) has traditionally been contraindicated due to concerns of upper-airway muscle relaxation and apnea prolongation leading to worsening hypoxemia. However, in accordance with recent advances in the understanding of OSA pathophysiology, some sedatives yield reductions in OSA severity in certain patients whereas other patients do indeed experience worsening hypoxemia. The current study represents the first investigation to examine the effects of any common sedative on pharyngeal muscle activity without continuous positive airway pressure. Contrary to previous beliefs, zopiclone increased the threshold for arousal without impairing genioglossus muscle activity. The detailed physiological assessments performed also provide insight into the key factors contributing to between-patient variability in OSA severity in response to sedatives such as zopiclone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5665/sleep.5622

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 105

Metadata

Authors
Carter, S. G., Berger, M. S., Carberry, J. C., Bilston, L. E., Butler, J. E., Tong, B. K. Y., Martins, R. T., Fisher, L. P., McKenzie, D. K., Grunstein, R. R., & Eckert, D. J.
Venue
Sleep
Published
2016-04-01
Volume
39
Issue
4
Pages
757-766
ISSN
  • 0161-8105 (ISSN-L)
  • 1550-9109
OpenAlex
W2318510082
Cited by
105
References
7
FWCI
10.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.